Navignostics AG
PrivateLast Round
Seed
Nov 9, 2022
Total Funding Raised
$8.69M
Company Overview
Navignostics AG operates in Healthcare & Life Sciences and is based in Horgen. Its latest recorded funding round was a Seed round in November 2022.
Navignostics AG is a precision oncology company that provides spatial single-cell proteomics analysis to guide personalized cancer treatment and accelerate drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navignostics AG Comparables
Compare Navignostics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sirona Dx | 86% | |
| Explicyte Immuno-Oncology | 80% | |
| Propath (UK) Limited | 79% |
For institutional investors. Book with your work email.
Navignostics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 9, 2022 | ||||
| Convertible Debt | Aug 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Navignostics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Seed |
| Ventura BioMed Investors | Seed |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 273% MoM.
- Mar 3, 2026
Monthly visitors grew 285% MoM, reaching 3.9K.
For institutional investors. Book with your work email.
Navignostics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Navignostics AG's valuation, stock price, and market status.
Is Navignostics AG a public or private company?
Navignostics AG is a private company.
What is the current stock price of Navignostics AG?
Navignostics AG is a private company, so its shares have no public market price. Caplight tracks Navignostics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Navignostics AG worth (valuation)?
Valuation information for Navignostics AG is not publicly available.
Can I buy Navignostics AG stock?
Navignostics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Navignostics AG's last funding round?
Navignostics AG's most recent funding round was Seed on November 9, 2022.
Who are the main investors in Navignostics AG?
Key investors in Navignostics AG include Think.Health, Ventura BioMed Investors, Zurcher Kantonalbank.
Will Navignostics AG IPO soon?
No public IPO plans have been announced for Navignostics AG.
How can I track Navignostics AG secondary market activity?
Caplight tracks bids, offers, and trades in Navignostics AG's shares on secondary markets.